Correlation between preoperative magnetic resonance spectroscopic data on high grade gliomas and morphology of Ki-67-positive tumor cell nuclei

Analytical and Quantitative Cytology and Histology

Volumn 25, Issue 3, 2003, Pages 131-138

  Nafe, Reinhold ^a   Herminghaus, Sebastian ^a   Raab, Peter ^b   Wagner, Sabine ^a   Pilatus, Ulrich ^a   Schlote, Wolfgang ^a   Zanella, Friedhelm ^a   Lanfermann, Heinrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Brain neoplasms; Glioblastoma; Glioma; Ki 67 antigen; Magnetic resonance; Morphometry; Spectroscopy

Indexed keywords

KI 67 ANTIGEN;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER GRADING; CELL DENSITY; CELL STRUCTURE; CLINICAL ARTICLE; CORRELATION ANALYSIS; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

BRAIN NEOPLASMS; CELL NUCLEUS; DISCRIMINANT ANALYSIS; FOURIER ANALYSIS; GLIOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAGNETIC RESONANCE SPECTROSCOPY; PREOPERATIVE CARE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037795232     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aiken NR, Gillies RJ: Phosphomonoester metabolism as a function of cell proliferative status and exogeneous precursors. Anticancer Res 1996;16:1393-1397
2. Alger JR, Frank JA, Bizzi A, Fulham MJ, DeSouza BX, Duhaney MO, Inscoe SW, Black JL, vanzijl PCM, Moonen CTW, DiChiro G: Metabolism of human gliomas: Assessment with 1H-MR spectroscopy and F-18-Fluorodeoxyglucose PET. Radiology 1990;177:633-641
3. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333-348
4. Byrd SE, Tomita T, Palka PS, Darling CF, Norfray JP, Fan J: Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors: Part II. Clinical analysis. J Natl Med Assoc 1996;88:717-723
5. Castillo M, Smith JK, Kwock L: Correlation of Myo-inositol levels and grading of cerebral astrocytomas. Am J Neuroradiol 2000;21:1645-1649
6. Chang L, McBride D, Miller BL, Cornford M, Booth RA, Buchthal SD, Ernst TM, Jenden DJ: Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 1995;5:157-163
7. Demaerel P, Johannik K, vanHecke P, vanOngeval C, Verellen S, Marchal G, Wilms G, Plets C, Goffin J, van Calenbergh F, Lammens M, Baert AL: Localized 1H-NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76
8. Falini A, Calabrese G, Origgi D, Lipari S, Triulzi F, Losa M, Scotti G: Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives. J Neurol 1996;243: 706-714
9. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715
10. Graves EE, Nelson SJ, Vigneron DB, Chin C, Verhey L, McDermott M, Larson D, Sneed PK, Chang S, Prados MD, Lamborn K, Dillon WP: A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 2000;46:319-328
11. Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neuro-Oncol 2000;50:215-226
12. Haase A, Frahm J, Hänicke W, Matthei D: 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341-344
13. Kleihues P, Cavenee WK: Pathology & Genetics: Tumors of the Nervous System. Lyon, IARC Press, 2000, pp 27-28
14. Klunk WE, Xu CJ, Panchalingham K, McClure RJ, Pettegrew JW: Analysis of magnetic resonance spectra by mole percent: Comparison of absolute units. Neurobiol Aging 1994;15:133-140
15. Kuesel AC, Sutherland GR, Halliday W, Smith IC: 1H-MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149-155
16. Luyten PR, Marien AJ, Heindel W, vanGerwen PH, Herholz K, denHollander JA, Friedmann G, Heiss WD: Metabolic imaging of patients with intracranial tumors: 1H-MR spectroscopic imaging and PET. Radiology 1990;176:791-799
17. Magnetom Vision: Applikations-Manual. Numaris version 31C. Erlangen, Germany, Siemens AG, 1999, pp 3-40
18. Meyerand ME, Pipas JM, Mamourian A, Tosteson TD, Dunn JF: Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. Am J Neuroradiol 1999;20: 117-123
19. Miller BL: A review of chemical issues in 1H-NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52
20. Miller BL, Chang L, Booth RA, Ernst T, Cornford M, Nikas D, McBride D, Jenden DJ: In vivo 1H MRS choline: Correlation with in vitro chemistry/histology. Life Sci 1996;58:1929-1935
21. Miller BL, McBride D, Riedy G, Caron M, Lipcamon J, O'Brien D: Changes in brain choline in 1H-MR spectroscopy. Bull Clin Neurosci 1990;55:115-122
22. Nafe R: Quantitative investigations of neuroepithelial tumors by means of Fourier analysis: Application for tumor grading and correlation with the Ki-67 proliferation index. Doctoral thesis, Johann Wolfgang Goethe University, 1999
23. Nafe R, Glienke W, Schlote W, Schneider B: EGFR gene-amplification in glioblastomas: Is there a relation with morphology of tumor cell nuclei and proliferative activity? Analyt Quant Cytol Histol 2001;23:135-143
24. Nafe R, Schlote W, Schneider B: Data analysis for comparative histometry in pathology: I. Classification procedures and other statistical methods. Electron J Pathol 2000;6:002-03.txt
25. Nafe R, Schlote W, Schneider B: Planimetric characterization of tumor cell nuclei in astrocytic tumors: Comparison of different tumor grades according to the WHO-Classification. Electron J Pathol 2000;6:004-01.txt
26. Nafe R, Schlote W, Schneider B: Shape analysis of tumor cell nuclei in ependymomas by means of Fourier analysis. Analyt Quant Cytol Histol 2000;22:475-482
27. Norfray JF, Tomita T, Byrd SE, Ross BD, Berger PA, Miller RS: Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors. Am J Radiol 1999; 173:119-125
28. Petrow OAC, Spencer DD, Alger JR, Prichard JW: High field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989; 39:1197-1202
29. Shimizu H, Kumabe T, Shirane R, Yoshimoto T: Correlation between choline level measured by proton MR spectroscopy and Ki-67 labelling index in gliomas. Am J Neuroradiol 2000; 21:659-665
30. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T: Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 2000;42:333-338
31. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, diChiro G: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524
32. Van der Veen JWC, De Beer PR, Luyten PR, Van Ormondt D: Accurate quantification of in vivo 31P-NMR signals using the variable projection method and prior knowledge. Magn Reson Med 1988;6:92-98